Key Financial Data Of Reporting Company

COSMOS Pharmaceutical Corporation - Filing #7360741

Concept 2023-09-01 to
2023-11-30
As at
2023-11-30
2023-06-01 to
2023-11-30
As at
2023-05-31
2022-06-01 to
2023-05-31
2022-09-01 to
2022-11-30
2022-06-01 to
2022-11-30
As at
2022-11-30
Key financial data of reporting company
Business results of reporting company
Net sales
476,430,000,000 JPY
827,697,000,000 JPY
404,016,000,000 JPY
Ordinary profit (loss)
17,346,000,000 JPY
33,086,000,000 JPY
16,900,000,000 JPY
Net assets
220,889,000,000 JPY
211,072,000,000 JPY
200,226,000,000 JPY
Total assets
436,155,000,000 JPY
420,967,000,000 JPY
378,885,000,000 JPY
Basic earnings (loss) per share
128.20
292.53
600.96
121.66
285.34
Diluted earnings per share
Equity-to-asset ratio
0.506 xbrli:pure
0.501 xbrli:pure
0.528 xbrli:pure
Net cash provided by (used in) operating activities
16,948,000,000 JPY
54,434,000,000 JPY
16,848,000,000 JPY
Net cash provided by (used in) investing activities
-28,545,000,000 JPY
-49,113,000,000 JPY
-21,295,000,000 JPY
Net cash provided by (used in) financing activities
-4,634,000,000 JPY
3,245,000,000 JPY
-3,240,000,000 JPY
Cash and cash equivalents
29,696,000,000 JPY
45,928,000,000 JPY
29,674,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.